Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1423053 MIAMI, FL
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$38,412,226
+$13,737,937 QoQ
Shares Held
1,972,893
+49.0% QoQ
Ownership
2.32%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#9
of 172 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Derivatives in MLTX

reported options exposure · as of Jun 30, 2026
CallValue
$5,317,257
CallShares
273,100
PutValue
$4,123,746
PutShares
211,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. MLTX ranks #32 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in MLTX

Export CSV
41 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,412,226 1,972,893
2026-06-30 $5,317,257 273,100
2026-06-30 $4,123,746 211,800
2026-03-31 $12,376,960 664,000
2026-03-31 $1,752,160 94,000
2026-03-31 $24,674,289 1,323,728
2025-12-31 $19,675,104 1,492,800
2025-12-31 $5,020,129 380,890
2025-12-31 $5,556,688 421,600
2025-09-30 $1,402,452 195,600
2025-09-30 $353,724 49,334
2025-09-30 $2,173,944 303,200
2025-06-30 $892,080 18,900
2025-06-30 $79,014,734 1,674,041
2025-06-30 $1,255,520 26,600
2025-03-31 $355,537 9,100
2025-03-31 $378,979 9,700
2025-03-31 $57,770,268 1,478,635
2024-12-31 $622,725 11,500
2024-12-31 $958,455 17,700
2024-12-31 $118,418,793 2,186,866
2024-09-30 $529,410 10,500
2024-09-30 $117,124,197 2,322,971
2024-09-30 $665,544 13,200
2024-06-30 $99,622,608 2,265,695
2024-06-30 $637,565 14,500
2024-06-30 $760,681 17,300
2024-03-31 $116,002,818 2,309,433
2024-03-31 $1,516,946 30,200
2024-03-31 $1,270,819 25,300
2023-12-31 $2,886,642 47,800
2023-12-31 $1,545,984 25,600
2023-12-31 $121,302,977 2,008,660
2023-09-30 $1,943,700 34,100
2023-09-30 $115,960,572 2,034,396
2023-09-30 $1,231,200 21,600
2023-06-30 $103,051,008 2,020,608
2023-03-31 $62,532,338 2,923,438
2022-12-31 $30,303,965 2,886,092
2022-09-30 $20,842,871 2,685,937
2022-06-30 $14,188,970 2,702,661